Skip to main content

Aberdeen Group plc

Source: SEC Form 13F · as of Mar 2026

Aberdeen Group plc holds 59 biotech & pharma companies tracked by BioSniper, totaling $1.37B in value as of Mar 2026 (SEC Form 13F).

Companies held

59

Total value held

$1.37B

BioSniper AIPage evidence connected

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.1,100,253$153.3M
REGNREGENERON PHARMACEUTICALS, INC.121,344$93.8M
QUREuniQure N.V.5,306,386$86.8M
MANEVeradermics Incorporated1,054,660$66.6M
ARGXARGENX SE82,106$60.0M
PCVXVaxcyte, Inc.978,969$56.9M
ABVXAbivax SA431,241$48.0M
ALNYALNYLAM PHARMACEUTICALS, INC.138,331$45.8M
INSMINSMED Inc277,016$45.3M
DNLIDenali Therapeutics Inc.1,854,446$35.6M
TECXTectonic Therapeutic, Inc.1,141,824$35.3M
SPRYARS Pharmaceuticals, Inc.4,113,617$33.0M
CYTKCYTOKINETICS INC483,274$31.9M
IMVTImmunovant, Inc.1,160,762$28.8M
NAMSNEWAMSTERDAM PHARMA CO N.V.837,005$26.8M
AXSMAxsome Therapeutics, Inc.149,688$25.3M
IRONDisc Medicine, Inc.375,614$24.0M
ARWRARROWHEAD PHARMACEUTICALS, INC.363,972$22.8M
SIONSionna Therapeutics, Inc.564,175$22.6M
SNYSanofi457,921$22.1M
VCELVericel Corp684,125$22.0M
JAZZJazz Pharmaceuticals plc114,128$21.6M
GPCRStructure Therapeutics Inc.391,809$18.9M
KNSAKiniksa Pharmaceuticals International, plc373,634$18.0M
LGNDLigand Pharmaceuticals Incorporated90,044$18.0M
RCUSArcus Biosciences, Inc.769,787$16.6M
TVTXTravere Therapeutics, Inc.557,147$16.6M
ANIPANI PHARMACEUTICALS INC206,123$15.9M
ARQTArcutis Biotherapeutics, Inc.645,066$15.2M
ADPTAdaptive Biotechnologies Corp1,070,627$14.9M
SUPNSUPERNUS PHARMACEUTICALS, INC.275,561$14.2M
NUVLNuvalent, Inc.123,577$12.7M
SMMTSummit Therapeutics Inc.665,364$12.6M
CRBPCorbus Pharmaceuticals Holdings, Inc.1,321,750$12.4M
INCYIncyte Corp.130,139$12.2M
JBIOJade Biosciences, Inc.867,284$12.2M
APGEApogee Therapeutics, Inc.143,379$12.1M
RVMDREVOLUTION MEDICINES, INC.114,767$11.2M
LENZLENZ Therapeutics, Inc.1,156,161$10.6M
COGTCogent Biosciences, Inc.272,707$10.5M
PVLAPALVELLA THERAPEUTICS, INC.81,081$10.1M
SLNOSOLENO THERAPEUTICS INC287,456$9.6M
IMUXIMMUNIC, INC.8,243,941$9.2M
IONSIONIS PHARMACEUTICALS INC113,843$8.5M
IMTXImmatics N.V.820,717$8.1M
AGMBAgomAb Therapeutics NV707,656$7.4M
RYTMRHYTHM PHARMACEUTICALS, INC.79,357$6.9M
MAZEMaze Therapeutics, Inc.226,227$6.8M
BHVNBiohaven Ltd.771,452$6.5M
PRQRProQR Therapeutics N.V.3,316,965$5.4M
TEVATeva Pharmaceutical Industries Limited163,497$4.9M
OCULOCULAR THERAPEUTIX, INC558,380$4.7M
ORKAOruka Therapeutics, Inc.75,680$3.7M
IMCRImmunocore Holdings plc116,857$3.5M
AVTXAvalo Therapeutics, Inc.171,679$2.6M
RCKTRocket Pharmaceuticals Inc.664,821$2.4M
MRNAModerna, Inc.17,951$912K
IOVAIOVANCE BIOTHERAPEUTICS, INC.155,000$544K
QNRXQuoin Pharmaceuticals, Ltd.75,000$495K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.